><ref id="bib1"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global tuberculosis control 2011.</source><publisher-name>Geneva</publisher-name><publisher-name>WHO Press</publisher-name><year>2011</year>Available at<x></x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/entity/tb/publications/global&#x0005f;report/2011/gtbr11&#x0005f;full.pdf">http://www.who.int/entity/tb/publications/global_report/2011/gtbr11_full.pdf</ext-link><x>
.
</x>(accessed 1 February 2012).</mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>M</given-names></name><name><surname>Oxlade</surname><given-names>O</given-names></name><name><surname>Lin</surname><given-names>HH</given-names></name></person-group><article-title>Modeling social, environmental and biological determinants of tuberculosis</article-title><source>Int J Tuberc Lung Dis</source><year>2011</year><volume>15 Suppl 2</volume><fpage>S64</fpage><lpage>S70</lpage><pub-id pub-id-type="pmid">21740661</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lienhardt</surname><given-names>C</given-names></name></person-group><article-title>From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis</article-title><source>Epidemiol Rev</source><year>2001</year><volume>23</volume><fpage>288</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">12192738</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Churchyard</surname><given-names>G</given-names></name></person-group><article-title>Epidemiology of HIV-associated tuberculosis</article-title><source>Curr Opin HIV AIDS</source><year>2009</year><volume>4</volume><fpage>325</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">19532072</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raviglione</surname><given-names>MC</given-names></name><name><surname>Snider</surname><given-names>DE</given-names><suffix>Jr</suffix></name><name><surname>Kochi</surname><given-names>A</given-names></name></person-group><article-title>Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic</article-title><source>JAMA</source><year>1995</year><volume>273</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">7807661</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Getahun</surname><given-names>H</given-names></name><name><surname>Gunneberg</surname><given-names>C</given-names></name><name><surname>Granich</surname><given-names>R</given-names></name><name><surname>Nunn</surname><given-names>P</given-names></name></person-group><article-title>HIV infection-associated tuberculosis: the epidemiology and the response</article-title><source>Clin Infect Dis</source><year>2010</year><volume>50 Suppl 3</volume><fpage>S201</fpage><lpage>S207</lpage><pub-id pub-id-type="pmid">20397949</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caminero</surname><given-names>JA</given-names></name></person-group><article-title>Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding</article-title><source>Int J Tuberc Lung Dis</source><year>2010</year><volume>14</volume><fpage>382</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">20202293</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>HS</given-names></name><name><surname>McDermid</surname><given-names>C</given-names></name><name><surname>Azevedo</surname><given-names>V</given-names></name><etal/></person-group><article-title>Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e13901</fpage><pub-id pub-id-type="pmid">21085569</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calver</surname><given-names>AD</given-names></name><name><surname>Falmer</surname><given-names>AA</given-names></name><name><surname>Murray</surname><given-names>M</given-names></name><etal/></person-group><article-title>Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa</article-title><source>Emerg Infect Dis</source><year>2010</year><volume>16</volume><fpage>264</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">20113557</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><etal/></person-group><article-title>Transmission of MDR and XDR tuberculosis in Shanghai, China</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e4370</fpage><pub-id pub-id-type="pmid">19190774</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nodieva</surname><given-names>A</given-names></name><name><surname>Jansone</surname><given-names>I</given-names></name><name><surname>Broka</surname><given-names>L</given-names></name><name><surname>Pole</surname><given-names>I</given-names></name><name><surname>Skenders</surname><given-names>G</given-names></name><name><surname>Baumanis</surname><given-names>V</given-names></name></person-group><article-title>Recent nosocomial transmission and genotypes of multidrug-resistant <italic>Mycobacterium tuberculosis</italic>. </article-title><source>Int J Tuberc Lung Dis</source><year>2010</year><volume>14</volume><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">20202300</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>The Stop TB Partnership and the World Health Organization</collab></person-group><source>The Global Plan to Stop TB, 2011&#x02013;2015.</source><publisher-name>Geneva</publisher-name><publisher-name>WHO Press</publisher-name><year>2010</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.stoptb.org/assets/documents/global/plan/TB&#x0005f;GlobalPlanToStopTB2011-2015.pdf">http://www.stoptb.org/assets/documents/global/plan/TB_GlobalPlanToStopTB2011-2015.pdf</ext-link><x>
.
</x>(accessed 30 January 2012).</mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>United Nations General Assembly</collab></person-group><source>United Nations Millennium Declaration</source><year>2000</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.un.org/millennium/declaration/ares552e.pdf">http://www.un.org/millennium/declaration/ares552e.pdf</ext-link><x>
.
</x>(accessed 14 April 2012).</mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>The Stop TB Partnership and the World Health Organization</collab></person-group><source>An International Roadmap for Tuberculosis Research.</source><publisher-name>Geneva</publisher-name><publisher-name>WHO Press</publisher-name><year>2011</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.stoptb.org/assets/documents/resources/publications/technical/tbresearchroadmap.pdf">http://www.stoptb.org/assets/documents/resources/publications/technical/tbresearchroadmap.pdf</ext-link><x>
.
</x>(accessed 14 April, 2012).</mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>The World Health Organization and the Stop TB Partnership</collab></person-group><source>Priorities in operational research to improve tuberculosis care and control.</source><publisher-name>Geneva</publisher-name><publisher-name>WHO Press</publisher-name><year>2011</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.who.int/tb/features&#x0005f;archive/operational&#x0005f;research&#x0005f;priorities/en/index.html">http://www.who.int/tb/features_archive/operational_research_priorities/en/index.html</ext-link><x>
.
</x>(accessed 1 February 2012).</mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Policy Cures</collab></person-group><source>G-FINDER 2011: neglected disease research and development.</source><publisher-name>Sydney</publisher-name><publisher-name>Policy Cures</publisher-name><year>2011</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://policycures.org/publications.html">http://policycures.org/publications.html</ext-link><x>
.
</x>(accessed 2 March 2012).</mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>NIAID Tuberculosis Working Group</collab></person-group><source>NIAID Research Agenda: multidrug-resistant and extensively drug-resistant tuberculosis.</source><publisher-name>Bethesda</publisher-name><publisher-name>NIAID</publisher-name><year>2007</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearchagenda.pdf">http://www.niaid.nih.gov/topics/tuberculosis/research/documents/mdrxdrresearchagenda.pdf</ext-link><x>
.
</x>(accessed 30 March 2012).</mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="other"><person-group person-group-type="author"><collab>Bill and Melinda Gates Foundation Global Health Program</collab></person-group><source>Strategy Overview: Tuberculosis</source><year>2009</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.gatesfoundation.org/global-health/Documents/tuberculosis-strategy.pdf">http://www.gatesfoundation.org/global-health/Documents/tuberculosis-strategy.pdf</ext-link><x>
.
</x>(accessed 2 May 2012).</mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Thole</surname><given-names>J</given-names></name></person-group><article-title>Tuberculosis vaccines: a strategic blueprint for the next decade</article-title><source>Tuberculosis</source><year>2012</year><volume>92 Suppl 1</volume><fpage>S6</fpage><lpage>S13</lpage><pub-id pub-id-type="pmid">22441160</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname><given-names>TM</given-names></name></person-group><article-title>The history of tuberculosis</article-title><source>Respir Med</source><year>2006</year><volume>100</volume><fpage>1862</fpage><lpage>1870</lpage><pub-id pub-id-type="pmid">16949809</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name><name><surname>Sabatelli</surname><given-names>L</given-names></name><name><surname>Achterberg</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>13980</fpage><lpage>13985</lpage><pub-id pub-id-type="pmid">19666590</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lonnroth</surname><given-names>K</given-names></name><name><surname>Raviglione</surname><given-names>M</given-names></name></person-group><article-title>Global epidemiology of tuberculosis: prospects for control</article-title><source>Semin Respir Crit Care Med</source><year>2008</year><volume>29</volume><fpage>481</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">18810682</pub-id></mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><article-title>Tuberculosis: what we don't know can, and does, hurt us</article-title><source>Science</source><year>2010</year><volume>328</volume><fpage>852</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">20466922</pub-id></mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Global Alliance for TB Drug Development</collab></person-group><article-title>Tuberculosis. Scientific blueprint for tuberculosis drug development</article-title><source>Tuberculosis (Edinb)</source><year>2001</year><volume>81 Suppl 1</volume><fpage>S1</fpage><lpage>S52</lpage></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>KB</given-names></name><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Ho</surname><given-names>MM</given-names></name><etal/></person-group><article-title>The second Geneva Consensus: recommendations for novel live TB vaccines</article-title><source>Vaccine</source><year>2010</year><volume>28</volume><fpage>2259</fpage><lpage>2270</lpage><pub-id pub-id-type="pmid">20074686</pub-id></mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>The New Diagnostics Working Group of the Stop TB Partnership</collab></person-group><source>Pathways to better diagnostics for tuberculosis: a blueprint for the development of TB diagnostics.</source><publisher-name>Geneva</publisher-name><publisher-name>WHO Press</publisher-name><year>2009</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2009/9789241598811&#x0005f;eng.pdf">http://whqlibdoc.who.int/publications/2009/9789241598811_eng.pdf</ext-link><x>
.
</x>(accessed 22 January 2012).</mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vynnycky</surname><given-names>E</given-names></name><name><surname>Fine</surname><given-names>PE</given-names></name></person-group><article-title>The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection</article-title><source>Epidemiol Infect</source><year>1997</year><volume>119</volume><fpage>183</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">9363017</pub-id></mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawn</surname><given-names>SD</given-names></name><name><surname>Wood</surname><given-names>R</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group><article-title>Changing concepts of &#x02018;latent tuberculosis infection' in patients living with HIV infection</article-title><source>Clin Dev Immunol</source><year>2011</year><volume>2011</volume>pii: 980594.</mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achkar</surname><given-names>JM</given-names></name><name><surname>Jenny-Avital</surname><given-names>ER</given-names></name></person-group><article-title>Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response</article-title><source>J Infect Dis</source><year>2011</year><volume>204 Suppl 4</volume><fpage>S1179</fpage><lpage>S1186</lpage><pub-id pub-id-type="pmid">21996700</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esmail</surname><given-names>H</given-names></name><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group><article-title>Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies</article-title><source>Drug Discov Today</source><year>2012</year><volume>17</volume><fpage>514</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">22198298</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rangaka</surname><given-names>MX</given-names></name><name><surname>Wilkinson</surname><given-names>KA</given-names></name><name><surname>Glynn</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis</article-title><source>Lancet Infect Dis</source><year>2012</year><volume>12</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">21846592</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandalakas</surname><given-names>AM</given-names></name><name><surname>Detjen</surname><given-names>AK</given-names></name><name><surname>Hesseling</surname><given-names>AC</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name></person-group><article-title>Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis</article-title><source>Int J Tuberc Lung Dis</source><year>2011</year><volume>15</volume><fpage>1018</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">21669030</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Diel</surname><given-names>R</given-names></name><name><surname>Loddenkemper</surname><given-names>R</given-names></name><name><surname>Nienhaus</surname><given-names>A</given-names></name></person-group><article-title>Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis</article-title><source>Chest</source>2012 Apr 5; doi:<pub-id pub-id-type="doi">10.1378/chest.11-3157</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gideon</surname><given-names>HP</given-names></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><article-title>Latent tuberculosis: what the host &#x02018;sees'</article-title><source>Immunol Res</source><year>2011</year><volume>50</volume><fpage>202</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">21717066</pub-id></mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walzl</surname><given-names>G</given-names></name><name><surname>Ronacher</surname><given-names>K</given-names></name><name><surname>Hanekom</surname><given-names>W</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group><article-title>Immunological biomarkers of tuberculosis</article-title><source>Nat Rev Immunol</source><year>2011</year><volume>11</volume><fpage>343</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">21475309</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Ellner</surname><given-names>JJ</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Ten challenges for TB biomarkers</article-title><source>Tuberculosis (Edinb)</source><year>2012</year><volume>92 Suppl 1</volume><fpage>S17</fpage><lpage>S20</lpage><pub-id pub-id-type="pmid">22441153</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menzies</surname><given-names>D</given-names></name><name><surname>Al Jahdali</surname><given-names>H</given-names></name><name><surname>Al Otaibi</surname><given-names>B</given-names></name></person-group><article-title>Recent developments in treatment of latent tuberculosis infection</article-title><source>Indian J Med Res</source><year>2011</year><volume>133</volume><fpage>257</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">21441678</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehlers</surname><given-names>S</given-names></name></person-group><article-title>Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis</article-title><source>Infection</source><year>2009</year><volume>37</volume><fpage>87</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">19308316</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trunz</surname><given-names>BB</given-names></name><name><surname>Fine</surname><given-names>P</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>1173</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">16616560</pub-id></mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randhawa</surname><given-names>AK</given-names></name><name><surname>Shey</surname><given-names>MS</given-names></name><name><surname>Keyser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Association of human TLR1 and TLR6 deficiency with altered immune responses to BCG vaccination in South African infants</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><fpage>e1002174</fpage><pub-id pub-id-type="pmid">21852947</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritz</surname><given-names>N</given-names></name><name><surname>Hanekom</surname><given-names>WA</given-names></name><name><surname>Robins-Browne</surname><given-names>R</given-names></name><name><surname>Britton</surname><given-names>WJ</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name></person-group><article-title>Influence of BCG vaccine strain on the immune response and protection against tuberculosis</article-title><source>FEMS Microbiol Rev</source><year>2008</year><volume>32</volume><fpage>821</fpage><lpage>841</lpage><pub-id pub-id-type="pmid">18616602</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>MJ</given-names></name><name><surname>Clagett</surname><given-names>B</given-names></name><name><surname>Fitzgerald</surname><given-names>H</given-names></name><etal/></person-group><article-title>Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><fpage>2811</fpage><lpage>2823</lpage><pub-id pub-id-type="pmid">22387630</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="other"><italic>Critical path to TB drug regimens</italic>. <year>2012</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://cptrinitiative.org/">http://cptrinitiative.org/</ext-link><x>
</x>(accessed 1 June 2012).</mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumberg</surname><given-names>HM</given-names></name><name><surname>Burman</surname><given-names>WJ</given-names></name><name><surname>Chaisson</surname><given-names>RE</given-names></name><etal/></person-group><article-title>American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>167</volume><fpage>603</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">12588714</pub-id></mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Guidelines for programmatic management of drug-resistant tuberculosis.</source><publisher-name>Geneva</publisher-name><publisher-name>WHO Press</publisher-name><year>2011</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2011/9789241501583&#x0005f;eng.pdf">http://whqlibdoc.who.int/publications/2011/9789241501583_eng.pdf</ext-link><x>
.
</x>(accessed 14 February 2012).</mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>NS</given-names></name><name><surname>Wright</surname><given-names>A</given-names></name><name><surname>Bai</surname><given-names>GH</given-names></name><etal/></person-group><article-title>Worldwide emergence of extensively drug-resistant tuberculosis</article-title><source>Emerging infectious diseases</source><year>2007</year><volume>13</volume><fpage>380</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">17552090</pub-id></mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDermott</surname><given-names>W</given-names></name></person-group><article-title>Microbial persistence</article-title><source>Yale J Biol Med</source><year>1958</year><volume>30</volume><fpage>257</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">13531168</pub-id></mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fauvart</surname><given-names>M</given-names></name><name><surname>de Groote</surname><given-names>VN</given-names></name><name><surname>Michiels</surname><given-names>J</given-names></name></person-group><article-title>Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies</article-title><source>J Med Microbiol</source><year>2011</year><volume>60</volume><supplement>Pt 6</supplement><fpage>699</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">21459912</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yew</surname><given-names>WW</given-names></name><name><surname>Barer</surname><given-names>MR</given-names></name></person-group><article-title>Targeting persisters for tuberculosis control</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><fpage>2223</fpage><lpage>2230</lpage><pub-id pub-id-type="pmid">22391538</pub-id></mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchison</surname><given-names>DA</given-names></name></person-group><article-title>The search for new sterilizing anti-tuberculosis drugs</article-title><source>Front Biosci</source><year>2004</year><volume>9</volume><fpage>1059</fpage><lpage>1072</lpage><pub-id pub-id-type="pmid">14977529</pub-id></mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasinskaya</surname><given-names>Y</given-names></name><name><surname>Sacks</surname><given-names>L</given-names></name></person-group><article-title>Models and approaches for anti-TB drug testing</article-title><source>Expert Rev Anti Infect Ther</source><year>2011</year><volume>9</volume><fpage>823</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">21810054</pub-id></mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Lienhardt</surname><given-names>C</given-names></name><name><surname>McIlleron</surname><given-names>H</given-names></name><name><surname>Nunn</surname><given-names>AJ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Global tuberculosis drug development pipeline: the need and the reality</article-title><source>Lancet</source><year>2010</year><volume>375</volume><fpage>2100</fpage><lpage>2109</lpage><pub-id pub-id-type="pmid">20488518</pub-id></mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyata</surname><given-names>T</given-names></name><name><surname>Cheigh</surname><given-names>CI</given-names></name><name><surname>Casali</surname><given-names>N</given-names></name><etal/></person-group><article-title>An adjunctive therapeutic vaccine against reactivation and post-treatment relapse tuberculosis</article-title><source>Vaccine</source><year>2012</year><volume>30</volume><fpage>459</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">22079078</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Deun</surname><given-names>A</given-names></name><name><surname>Salim</surname><given-names>MA</given-names></name><name><surname>Das</surname><given-names>AP</given-names></name><name><surname>Bastian</surname><given-names>I</given-names></name><name><surname>Portaels</surname><given-names>F</given-names></name></person-group><article-title>Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh</article-title><source>Int J Tuberc Lung Dis</source><year>2004</year><volume>8</volume><fpage>560</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">15137531</pub-id></mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Institute of Allergy and Infectious Diseases</collab></person-group><source>Restructuring the NIAID Clinical Trials Networks.</source><publisher-name>Bethesda</publisher-name><publisher-name>National Institute of Allergy and Infectious Diseases</publisher-name><year>2012</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.niaid.nih.gov/labsandresources/restructuring">http://www.niaid.nih.gov/labsandresources/restructuring</ext-link><x>
</x>(accessed 14 February 2012).</mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Institute of Allergy and Infectious Diseases</collab></person-group><source>Resources for researchers.</source><publisher-name>Bethesda</publisher-name><publisher-name>National Institute of Allergy and Infectious Diseases</publisher-name><year>2012</year>Available at<x>
</x><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.niaid.nih.gov/labsandresources/resources">http://www.niaid.nih.gov/labsandresources/resources</ext-link><x>
</x>(accessed 1 June 2012).</mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuermberger</surname><given-names>EL</given-names></name><name><surname>Yoshimatsu</surname><given-names>T</given-names></name><name><surname>Tyagi</surname><given-names>S</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name><name><surname>Grosset</surname><given-names>JH</given-names></name></person-group><article-title>Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG</article-title><source>Infect Immun</source><year>2004</year><volume>72</volume><fpage>1065</fpage><lpage>1071</lpage><pub-id pub-id-type="pmid">14742554</pub-id></mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCune</surname><given-names>RM</given-names></name><name><surname>Feldmann</surname><given-names>FM</given-names></name><name><surname>Lambert</surname><given-names>HP</given-names></name><name><surname>McDermott</surname><given-names>W</given-names></name></person-group><article-title>Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues</article-title><source>J Exp Med</source><year>1966</year><volume>123</volume><fpage>445</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">4957010</pub-id></mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCune</surname><given-names>RM</given-names></name><name><surname>Feldmann</surname><given-names>FM</given-names></name><name><surname>McDermott</surname><given-names>W</given-names></name></person-group><article-title>Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli</article-title><source>J Exp Med</source><year>1966</year><volume>123</volume><fpage>469</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">4957011</pub-id></mixed-citation></ref></